Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.
暂无分享,去创建一个
Gerard Pasterkamp | Manuel Salto-Tellez | Andre Choo | Fatih Arslan | Tian Sheng Chen | Sai Kiang Lim | Leo Timmers | M. Salto‐Tellez | G. Pasterkamp | S. Lim | A. Choo | R. C. Lai | T. Chen | R. El Oakley | C. Lee | L. Timmers | F. Arslan | D. D. de Kleijn | May May Lee | N. Sze | Dominique P V de Kleijn | Ruenn Chai Lai | Chuen Neng Lee | Reida Menshawe El Oakley | Newman Siu Kwan Sze | M. Lee
[1] P. Doevendans,et al. Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody , 2010, Circulation.
[2] Tian Sheng Chen,et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs , 2009, Nucleic acids research.
[3] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[4] P. Quesenberry,et al. The Paradoxical Dynamism of Marrow Stem Cells: Considerations of Stem Cells, Niches, and Microvesicles , 2008, Stem Cell Reviews.
[5] Cicek Gercel-Taylor,et al. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.
[6] P. Doevendans,et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. , 2008, Stem cell research.
[7] H. Northoff,et al. Cardioprotection and cardiac regeneration by mesenchymal stem cells. , 2008, Panminerva medica.
[8] Hui Zhao,et al. Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells*S , 2007, Molecular & Cellular Proteomics.
[9] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[10] D. Knight. Editorial overview: cardioprotective drugs for myocardial ischemic injury--a therapeutic area at risk. , 2007, Current opinion in investigational drugs.
[11] M. Salto‐Tellez,et al. Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs , 2007, Stem cells.
[12] Sascha Keller,et al. Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.
[13] A. Caplan,et al. Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.
[14] J Ratajczak,et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.
[15] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.
[17] J. Minguell,et al. Mesenchymal Stem Cells and the Treatment of Cardiac Disease , 2006, Experimental biology and medicine.
[18] Shiaw-Min Hwang,et al. Cytokine interactions in mesenchymal stem cells from cord blood. , 2005, Cytokine.
[19] J. Hare,et al. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy , 2005, Basic Research in Cardiology.
[20] X. Qin,et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. , 2005, The Annals of thoracic surgery.
[21] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[22] G. Raposo,et al. Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.
[23] M. Pittenger,et al. Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.
[24] G. Bernardi,et al. [Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[25] C M Gibson,et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.
[26] A. Saraste,et al. Apoptosis in human acute myocardial infarction. , 1997, Circulation.
[27] C. Melief,et al. B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.
[28] R. Rosell,et al. Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer. , 2009, Clinical lung cancer.
[29] M. Vidal,et al. Proteomic analysis of secreted exosomes. , 2007, Sub-cellular biochemistry.
[30] E. Bouhassira,et al. Congenital Factor V Deficiency Low Plasma Levels of Tissue Factor Pathway Inhibitor in Patients With , 2006 .